Treatment of sarcoidosis;Traitement de la sarcoïdose

Revue de Medecine Interne

Volumn 32, Issue 2, 2011, Pages 109-113

  Londner, C ^a   Zendah, I ^a,b   Freynet, O ^a   Carton, Z ^a   Dion, G ^a   Nunes, H ^a   Valeyre, D ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

Author keywords

Anti TNF agents; Chloroquine; Corticosteroids; Hydroxychlorquine; Immunosuppressive drugs; Sarcoidosis; Treatment

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; PREDNISONE;

COUGHING; DISEASE EXACERBATION; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG INDICATION; DRUG RESPONSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRIDOCYCLITIS; LOW DRUG DOSE; OUTCOME ASSESSMENT; PATHOLOGICAL ANATOMY; PATIENT MONITORING; REMISSION; SARCOIDOSIS; SHORT SURVEY; SKIN DEFECT; SKIN DISEASE; TREATMENT DURATION;

EID: 78751627152     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2010.10.351     Document Type: Short Survey

References (40)

1. Hunninghake G.W., Costabel U., Ando M., Baughman R.P., Cordier J.F., du Bois R., et al. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999, 16:149-173.
2. Nunes H., Soler P., Valeyre D. Pulmonary sarcoidosis. Allergy 2005, 60:565-582.
3. Baughman R.P., Costabel U., du Bois R.M. Treatment of sarcoidosis. Clin Chest Med 2008, 29:533-548.
4. Lazar C.A., Culver D.A. Treatment of sarcoidosis. Sem Respir Crit Care Med 2010, 31:501-518.
5. Ianuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N Engl J Med 2007, 357:2153-2165.
6. James D.G., Carstairs L.S., Trowell J., Sharma O.P. Treatment of sarcoidosis. Report of a controlled study. Lancet 1967, 2:526-528.
7. Paramothayan S., Jones P.W. Corticosteroid therapy in sarcoidosis: a systematic review. JAMA 2002, 287:1301-1307.
8. Valeyre D., Cottin V. Sarcoïdose pulmonaire. La pneumologie fondée sur les preuves 2008, Margaux orange, Paris, p. 473-9.
9. Chapelon C., Ziza J.M., Piette J.C., Levy Y., Raguin G., Wechsler B., et al. Neurosarcoidosis: signs, course, and treatment in 35 confirmed cases. Medicine (Baltimore) 1990, 69:261-276.
10. Chapelon-Abric C., de Zuttere D., Duhaut P., Veyssier P., Wechsler B., Huong D.L., et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine 2004, 83:315-334.
11. Cohen-Aubart F., Galanaud D., Grabli D., Haroche J., Amoura Z., Chapelon-Abric C., et al. Spinal cord sarcoidosis: clinical and laboratory profile and outcome in a 31-patient case-contolled study. Medicine (Baltimore) 2010, 89:133-140.
12. Aubart F., Ouayoun M., Brauner M., Attali P., Kambouchner M., Valeyre D., et al. Sinonasal involvement of sarcoidosis: a control-study of 20 patients. Medicine (Baltimore) 2006, 85:365-371.
13. Bihan H., Christozova V., Dumas J.L., Jomaa R., Valeyre D., Tazi A., et al. Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in nine patients and review of the literature. Medicine (Baltimore) 2007, 1110:271-284.
14. Mahévas M., Lescure F.X., Boffa J.J., Delastour V., Belenfant X., Chapelon C., et al. Renal sarcoidosis: clinical, biological and histological presentation and outcome. A study of 47 patients. Medicine (Baltimore) 2009, 88:98-106.
15. Bower J.S., Belen J.E., Dantzker D.R. Manifestations and treatment of laryngeal sarcoidosis. Am Rev Respir Dis 1980, 122:325-332.
16. Meyniel C., Wiertlewski S. Névrites optiques. Rev Med Interne 2010, 31:481-485.
17. Baughman R.P., Winget D.B., Lower E.E. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000, 17:60-66.
18. Gonnelli S., Rottoli P., Cepollaro C., Pondrelli C., Cappiello V., Vagliasindi M., et al. Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients. Calcif Tissue Int 1997, 61:382-385.
19. Baughman R.P., Lower E.E. Evidence-based therapy for cutaneous sarcoidosis. Clin Dermatol 2007, 25:334-340.
20. Baltzan M., Mehta S., Kirkham T.H., Cosio M.G. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 1999, 160:192-197.
21. Muller-Querheim J., Kienast K., Held M., Pfeifer S., Costabel U. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J 1999, 14:1117-1122.
22. Baughman R.P., Lower E.E. Leflunomide for chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004, 21:43-48.
23. Baughman R.P., Judson M.A., Teistein A.S., Moller D.R., Lower E.E. Thalidomide for chronic sarcoidosis. Chest 2002, 122:227-232.
24. Baughman R.P., Lower E.E. Novel therapies for sarcoidosis. Semin Respir Crit Care Med 2007, 28:128-133.
25. Baughman R.P., Drent M., Kavuru M. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006, 174:795-802.
26. Toussirot E., Pertuiset E. Agents anti-TNFα et sarcoïdose. Rev Med Interne 2010, 31:828-837.
27. Jounieaux F., Chapelon C., Valeyre D., Israel-Biet D., Cottin V., Tazi A., et al. Infliximab et sarcoïdose chronique: l'expérience française. Rev Mal Respir 2010, 27:685-692.
28. Baughman R.P., Lower E.E., Bradley D.A., Raymond L.A., Kaufman A. Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Chest 2005, 128:1062-1067.
29. Utz J.P., Limper A.H., Kalra S., Spechs U., Scott J.P., Vuk-Pavlovic Z., et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 2003, 124:177-185.
30. Bachelez H., Senet P., Cadranel J., Kaoukhov A., Dubertret L. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 2001, 137:69-73.
31. Nunes H., Humbert M., Capron F., Brauner M., Sitbon O., Battesti J.P., et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006, 61:68-74.
32. Palmero V., Sulica R. Sarcoidosis-associated pulmonary hypertension: assessment and management. Semin Respir Crit Care Med 2010, 31:494-500.
33. Shah L. Lung transplantation in sarcoidosis. Semin Respir Crit Care Med 2007, 28:134-140.
34. Oni A.A., Hershberger R.E., Norman D.J., Dray J., Hovaguimian H., Cobanoglu A.M., et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 1992, 11:367-369.
35. Dumas J.L., Valeyre D., Chapelon-Abric C., Belin C., Piette J.C., Tandjaoui-Lambiotte H., et al. Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy. Radiology 2000, 214:411-420.
36. Nunes H., Brillet P.Y., Valeyre D., Brauner M.W., Wells A.U. Imaging in sarcoidosis. Semin Respir Crit Care Med 2007, 28:102-120.
37. Brauner M.W., Lenoir S., Grenier P., Cluzel P., Battesti J.P., Valeyre D. Pulmonary sarcoidosis. CT assessment of lesion reversibility. Radiology 1992, 182:349-354.
38. Chambellan A., Turbie P., Nunes H., Brauner M., Battesti J.P., Valeyre D. Endoluminal stenosis of proximal bronchi in sarcoidosis: bronchoscopy, function and evolution. Chest 2005, 127:472-481.
39. Naccache J.M., Lavole A., Nunes H., Lamberto C., Letoumelin P., Brauner M., et al. HRCT imaging of airways in sarcoidosis with airflow obstruction. J Comput Assist Tomogr 2008, 32:905-912.
40. Quatraro A., Consoli G., Magno M., Caretta F., Nardozza A., Ceriello A., et al. Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug?. Ann Intern Med 1990, 112:678-681.